Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1750052723;52724;52725 chr2:178608385;178608384;178608383chr2:179473112;179473111;179473110
N2AB1585947800;47801;47802 chr2:178608385;178608384;178608383chr2:179473112;179473111;179473110
N2A1493245019;45020;45021 chr2:178608385;178608384;178608383chr2:179473112;179473111;179473110
N2B843525528;25529;25530 chr2:178608385;178608384;178608383chr2:179473112;179473111;179473110
Novex-1856025903;25904;25905 chr2:178608385;178608384;178608383chr2:179473112;179473111;179473110
Novex-2862726104;26105;26106 chr2:178608385;178608384;178608383chr2:179473112;179473111;179473110
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: P
  • RefSeq wild type transcript codon: CCC
  • RefSeq wild type template codon: GGG
  • Domain: Fn3-15
  • Domain position: 31
  • Structural Position: 34
  • Q(SASA): 0.6143
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
P/H rs1384771900 -0.3 1.0 N 0.624 0.498 0.59498951386 gnomAD-2.1.1 8.19E-06 None None None None I None 0 0 None 0 5.73E-05 None 0 None 0 9.07E-06 0
P/S None None 0.995 N 0.628 0.391 0.311079019809 gnomAD-4.0.0 1.20032E-06 None None None None I None 0 0 None 0 0 None 0 0 1.3125E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
P/A 0.0877 likely_benign 0.0952 benign -0.571 Destabilizing 0.619 D 0.433 neutral N 0.508747385 None None I
P/C 0.5142 ambiguous 0.5976 pathogenic -0.649 Destabilizing 1.0 D 0.634 neutral None None None None I
P/D 0.3748 ambiguous 0.5002 ambiguous -0.253 Destabilizing 0.999 D 0.683 prob.neutral None None None None I
P/E 0.225 likely_benign 0.2955 benign -0.365 Destabilizing 0.999 D 0.687 prob.neutral None None None None I
P/F 0.5742 likely_pathogenic 0.6703 pathogenic -0.769 Destabilizing 1.0 D 0.637 neutral None None None None I
P/G 0.3635 ambiguous 0.4087 ambiguous -0.715 Destabilizing 0.988 D 0.61 neutral None None None None I
P/H 0.2056 likely_benign 0.2609 benign -0.256 Destabilizing 1.0 D 0.624 neutral N 0.489249684 None None I
P/I 0.3174 likely_benign 0.398 ambiguous -0.341 Destabilizing 0.999 D 0.671 neutral None None None None I
P/K 0.2193 likely_benign 0.2908 benign -0.444 Destabilizing 0.998 D 0.693 prob.neutral None None None None I
P/L 0.1506 likely_benign 0.1768 benign -0.341 Destabilizing 0.998 D 0.68 prob.neutral D 0.523256148 None None I
P/M 0.3296 likely_benign 0.3833 ambiguous -0.312 Destabilizing 1.0 D 0.62 neutral None None None None I
P/N 0.305 likely_benign 0.3783 ambiguous -0.188 Destabilizing 1.0 D 0.677 prob.neutral None None None None I
P/Q 0.1466 likely_benign 0.1761 benign -0.443 Destabilizing 1.0 D 0.657 neutral None None None None I
P/R 0.1732 likely_benign 0.2227 benign 0.092 Stabilizing 0.999 D 0.675 prob.neutral N 0.479045468 None None I
P/S 0.1372 likely_benign 0.1632 benign -0.59 Destabilizing 0.995 D 0.628 neutral N 0.490450999 None None I
P/T 0.1176 likely_benign 0.143 benign -0.598 Destabilizing 0.998 D 0.634 neutral N 0.473916906 None None I
P/V 0.2133 likely_benign 0.249 benign -0.382 Destabilizing 0.998 D 0.637 neutral None None None None I
P/W 0.7395 likely_pathogenic 0.8094 pathogenic -0.833 Destabilizing 1.0 D 0.67 neutral None None None None I
P/Y 0.5133 ambiguous 0.6057 pathogenic -0.533 Destabilizing 1.0 D 0.637 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.